InsidersTradesSigma
Follow the 명인제약 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 명인제약 has logged 1 public disclosures. Market capitalisation: €616.1bn. The latest transaction was reported on 6 April 2026 (Mixed). Among the most active insiders: 이동철. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Myungjin Pharmaceutical 是一家韩国制药公司，专注于药物的开发和制造。该公司在韩国证券交易所 (XKRX) 上市。